# Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

> **NCT03698461** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Colorectal Neoplasms
- Neoplasm Metastasis
- Colonic Neoplasms
- Rectal Neoplasms

## Interventions

- **DRUG:** Atezolizumab
- **DRUG:** Bevacizumab
- **DRUG:** Oxaliplatin
- **DRUG:** Levoleucovorin
- **DRUG:** 5-FU

## Key facts

- **NCT ID:** NCT03698461
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2021-12-22
- **Final completion:** 2023-10-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698461, "Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03698461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*